Talphera Net Income
| TLPH Stock | 0.91 0.01 1.11% |
As of the 4th of March, Talphera has the Coefficient Of Variation of (1,055), risk adjusted performance of (0.06), and Variance of 20.94. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Talphera, as well as the relationship between them.
Talphera's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Talphera's valuation are provided below:Talphera does not presently have any fundamental trend indicators for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Is there potential for Pharmaceuticals market expansion? Will Talphera introduce new products? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Talphera's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Talphera 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Talphera's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Talphera.
| 12/04/2025 |
| 03/04/2026 |
If you would invest 0.00 in Talphera on December 4, 2025 and sell it all today you would earn a total of 0.00 from holding Talphera or generate 0.0% return on investment in Talphera over 90 days. Talphera is related to or competes with Scynexis, Apimeds Pharmaceuticals, MIRA Pharmaceuticals, Nutriband, IBio Common, Iterum Therapeutics, and P3 Health. Teliphone Corporation, a telecommunications company, offer voice, data, and cloud services in Canada. More
Talphera Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Talphera's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Talphera upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.10) | |||
| Maximum Drawdown | 26.9 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 5.88 |
Talphera Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Talphera's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Talphera's standard deviation. In reality, there are many statistical measures that can use Talphera historical prices to predict the future Talphera's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | 0.3179 |
Talphera March 4, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | 0.3279 | |||
| Mean Deviation | 2.94 | |||
| Coefficient Of Variation | (1,055) | |||
| Standard Deviation | 4.58 | |||
| Variance | 20.94 | |||
| Information Ratio | (0.10) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (0.65) | |||
| Treynor Ratio | 0.3179 | |||
| Maximum Drawdown | 26.9 | |||
| Value At Risk | (6.67) | |||
| Potential Upside | 5.88 | |||
| Skewness | 1.27 | |||
| Kurtosis | 7.25 |
Talphera Backtested Returns
Talphera owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0948, which indicates the firm had a -0.0948 % return per unit of risk over the last 3 months. Talphera exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Talphera's Risk Adjusted Performance of (0.06), coefficient of variation of (1,055), and Variance of 20.94 to confirm the risk estimate we provide. The entity has a beta of -1.4, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Talphera are expected to decrease by larger amounts. On the other hand, during market turmoil, Talphera is expected to outperform it. At this point, Talphera has a negative expected return of -0.43%. Please make sure to validate Talphera's total risk alpha, skewness, as well as the relationship between the Skewness and day median price , to decide if Talphera performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.29 |
Poor predictability
Talphera has poor predictability. Overlapping area represents the amount of predictability between Talphera time series from 4th of December 2025 to 18th of January 2026 and 18th of January 2026 to 4th of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Talphera price movement. The serial correlation of 0.29 indicates that nearly 29.0% of current Talphera price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.29 | |
| Spearman Rank Test | 0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Talphera reported net income of (13 Million). This is 103.81% lower than that of the Pharmaceuticals sector and 96.62% lower than that of the Health Care industry. The net income for all United States stocks is 102.28% higher than that of the company.
Talphera Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Talphera's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Talphera could also be used in its relative valuation, which is a method of valuing Talphera by comparing valuation metrics of similar companies.Talphera is currently under evaluation in net income category among its peers.
Talphera Fundamentals
| Return On Equity | -0.86 | ||||
| Return On Asset | -0.31 | ||||
| Current Valuation | 21.21 M | ||||
| Shares Outstanding | 46.61 M | ||||
| Shares Owned By Insiders | 26.89 % | ||||
| Shares Owned By Institutions | 43.74 % | ||||
| Number Of Shares Shorted | 1.11 M | ||||
| Price To Book | 2.22 X | ||||
| Price To Sales | 1,518 X | ||||
| Gross Profit | (5.77 M) | ||||
| EBITDA | (15.16 M) | ||||
| Net Income | (13 M) | ||||
| Cash And Equivalents | 90.29 K | ||||
| Cash Per Share | 0.01 X | ||||
| Total Debt | 6.53 M | ||||
| Debt To Equity | 0.17 % | ||||
| Current Ratio | 0.64 X | ||||
| Book Value Per Share | 0.42 X | ||||
| Cash Flow From Operations | (12.68 M) | ||||
| Short Ratio | 6.17 X | ||||
| Earnings Per Share | (0.38) X | ||||
| Target Price | 3.25 | ||||
| Number Of Employees | 13 | ||||
| Beta | 0.49 | ||||
| Market Capitalization | 42.5 M | ||||
| Total Asset | 18.24 M | ||||
| Retained Earnings | (457.23 M) | ||||
| Working Capital | 6.77 M | ||||
| Current Asset | 9.04 M | ||||
| Current Liabilities | 14.14 M | ||||
| Net Asset | 18.24 M |
About Talphera Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Talphera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talphera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talphera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out For more detail on how to invest in Talphera Stock please use our How to Invest in Talphera guide.You can also try the AI Portfolio Prophet module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is there potential for Pharmaceuticals market expansion? Will Talphera introduce new products? Factors like these will boost the valuation of Talphera. If investors know Talphera will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Talphera listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Talphera is measured differently than its book value, which is the value of Talphera that is recorded on the company's balance sheet. Investors also form their own opinion of Talphera's value that differs from its market value or its book value, called intrinsic value, which is Talphera's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Talphera's market value can be influenced by many factors that don't directly affect Talphera's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Talphera's value and its price as these two are different measures arrived at by different means. Investors typically determine if Talphera is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Talphera's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.